+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

  • PDF Icon

    Report

  • 280 Pages
  • July 2023
  • Region: Global
  • Azoth Analytics
  • ID: 5842964
Description Jump to:
The publisher has released a research report titled “Global Seasonal Influenza Vaccine Market (2023 Edition)” which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine - IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supply) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, Australia, South Korea). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Seasonal Influenza Vaccine Market is expected to generate USD 9.3 Billion by the end of 2029, up from USD 5.8 Billion in 2022. A favourable growth element for the Global Seasonal Influenza Vaccine market is the changing weather conditions, rapid transmissions of respiratory diseases, increasing awareness, and increasing demand for retail. Influenza is a significant global health concern, causing a considerable burden of illness, hospitalizations, and deaths each year. As per WHO, an estimated 1 Million people worldwide are infected by seasonal influenza every year, out of which an estimated 290,000 - 650,000 deaths occur due to flu each year.

During the forecast period, 2024-2029, Global Seasonal Influenza Vaccines expected to expand at a CAGR of 7.61%. The global seasonal influenza vaccine is driven by increasing awareness about flu prevention, rising healthcare expenditure, and growing government initiatives for immunization programs.

Prevention and control of seasonal influenza are primarily achieved through annual vaccination. The flu vaccine is formulated each year to protect against the most prevalent strains of the virus. There are different types of influenza vaccines available in the market. The most common ones include trivalent vaccines (protect against three flu strains) and quadrivalent vaccines (protect against four flu strains). These vaccines may be administered through injection (inactivated vaccine) or nasal spray (live attenuated vaccine).

Retail pharmacies provide easy access to seasonal influenza vaccines for the general population. With numerous pharmacy locations in communities, people can conveniently receive their vaccinations without the need for appointments or visits to healthcare facilities, which may be more time-consuming and less accessible.

Leveraging digital technologies and tracking systems in the seasonal influenza vaccine market offers opportunities to improve vaccine distribution, enhance vaccination campaigns, ensure vaccine safety, and enable data-driven decision-making. By harnessing the power of digital solutions, stakeholders can optimize vaccine delivery, increase vaccine uptake, and ultimately contribute to better influenza prevention and control efforts.

Scope of the Report

  • The report analyses the Seasonal Influenza Vaccine Market by Value (USD Million)
  • The report presents the analysis of Seasonal Influenza Vaccine Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029
  • The report analyses the Seasonal Influenza Vaccine Market by Vaccine Type (Inactivated Influenza Vaccine (IIV), Live Attenuated Influenza Vaccine (LAIV))
  • The report analyses the Seasonal Influenza Vaccine Market by Valency (Quadrivalent, Trivalent)
  • The report analyses the Seasonal Influenza Vaccine Market by Age Group (Pediatrics, Adults, Elderly)
  • The report analyses the Seasonal Influenza Vaccine Market by Distribution Channel (Hospitals, Pharmacies, Government Supply)
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Seqirus, GlaxoSmithKline, Sanofi, AstraZeneca, Abbott Laboratories, Viatris, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, and Dalian Aleph Biomedical.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Leveraging digital technologies and tracking systems
2.2 Improved vaccine distribution and access
3. Global Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on Seasonal Influenza Vaccine Market
3.2 Prequalified Seasonal Influenza Vaccine Worldwide
3.3 Influenza Vaccination Rates
3.4 Quadrivalent Influenza Vaccine Composition
3.5 Average Price Analysis
3.6 Global Seasonal Influenza Vaccine Market: Dashboard
3.7 Global Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
3.8 Global Seasonal Influenza Vaccine Market: Market Production Volume and CAGR, 2019-2029 (in Billion Doses)
3.9 Degree of Impact of Covid 19 on Influenza Vaccine Market
3.10 Global Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
3.10.1 Global Seasonal Influenza Vaccine Market, By Vaccine Type Overview
3.10.2 Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
3.10.3 Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
3.11 Global Seasonal Influenza Vaccine Market Segmentation: By Valency
3.11.1 Global Seasonal Influenza Vaccine Market, By Valency Overview
3.11.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
3.11.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
3.12 Global Seasonal Influenza Vaccine Market Segmentation: By Age Group
3.12.1 Global Seasonal Influenza Vaccine Market, By Age Group Overview
3.12.2 Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
3.12.3 Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
3.12.4 Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
3.13 Global Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
3.13.1 Global Seasonal Influenza Vaccine Market, By Distribution Channel Overview
3.13.2 Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
3.13.3 Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
3.13.4 Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
4. Global Seasonal Influenza Vaccine Market, Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)
5.1 Americas Seasonal Influenza Vaccine Market: Snapshot
5.2 Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.3 Americas Seasonal Influenza Vaccine Market: Key Factors
5.4 Americas Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
5.4.1 Americas Seasonal Influenza Vaccine Market, By Vaccine Type Overview
5.4.2 Americas Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
5.4.3 Americas Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
5.5 Americas Seasonal Influenza Vaccine Market Segmentation: By Valency
5.5.1 Americas Seasonal Influenza Vaccine Market, By Valency Overview
5.5.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
5.5.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
5.6 Americas Seasonal Influenza Vaccine Market Segmentation: By Age Group
5.6.1 Americas Seasonal Influenza Vaccine Market, By Age Group Overview
5.6.2 Americas Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
5.6.3 Americas Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
5.6.4 Americas Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
5.7 Americas Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
5.7.1 Americas Seasonal Influenza Vaccine Market, By Distribution Channel Overview
5.7.2 Americas Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
5.7.3 Americas Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
5.7.4 Americas Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
5.8 Americas Seasonal Influenza Vaccine Market Segmentation: By Country
5.8.1 United States Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.1.1 United States Seasonal Influenza Vaccine Market, By Vaccine Type
5.8.1.2 United States Seasonal Influenza Vaccine Market, By Valency
5.8.1.3 United States Seasonal Influenza Vaccine Market, By Age Group
5.8.1.4 United States Seasonal Influenza Vaccine Market, By Distribution Channel
5.8.2 Canada Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.2.1 Canada Seasonal Influenza Vaccine Market, By Vaccine Type
5.8.2.2 Canada Seasonal Influenza Vaccine Market, By Valency
5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Age Group
5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Distribution Channel
5.8.3 Rest of Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.3.1 Rest of Americas Seasonal Influenza Vaccine Market, By Vaccine Type
5.8.3.2 Rest of Americas Seasonal Influenza Vaccine Market, By Valency
5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Age Group
5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel
6.Europe Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)
6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot
6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.3 Europe Seasonal Influenza Vaccine Market: Key Factors
6.4 Europe Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)
6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
6.5 Europe Seasonal Influenza Vaccine Market Segmentation: By Valency
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By, Valency Overview
6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
6.6 Europe Seasonal Influenza Vaccine Market Segmentation: By Age Group
6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview
6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
6.7 Europe Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot
6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.3 Europe Seasonal Influenza Vaccine Market: Key Factors
6.4 Europe Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By, Vaccine Overview
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By, By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)
6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
6.5 Europe Seasonal Influenza Vaccine Market Segmentation: By Valency
6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview
6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
6.6 Europe Seasonal Influenza Vaccine Market Segmentatio: By Age Group
6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview
6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
6.7 Europe Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
6.7.1 Europe Seasonal Influenza Vaccine Market, By Distribution Channel Overview
6.7.2 Europe Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
6.7.3 Europe Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
6.7.4 Europe Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
6.8 Europe Seasonal Influenza Vaccine Market Segmentation: By Country
6.8.1 Germany Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.1.1 Germany Seasonal Influenza Vaccine Market, By Vaccine Type
6.8.1.2 Germany Seasonal Influenza Vaccine Market, By Valency
6.8.1.3 Germany Seasonal Influenza Vaccine Market, By Age Group
6.8.1.4 Germany Seasonal Influenza Vaccine Market, By Distribution Channel
6.8.2 United Kingdom Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.2.1 United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type
6.8.2.2 United Kingdom Seasonal Influenza Vaccine Market, By Valency
6.8.2.3 United Kingdom Seasonal Influenza Vaccine Market, By Age Group
6.8.2.4 United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel
6.9.3 France Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.9.3.1 France Seasonal Influenza Vaccine Market, By Vaccine Type
6.9.3.2 France Seasonal Influenza Vaccine Market, By Valency
6.9.3.3 France Seasonal Influenza Vaccine Market, By Age Group
6.9.3.4 France Seasonal Influenza Vaccine Market, By Distribution Channel
6.9.4 Spain Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.9.4.1 Spain Seasonal Influenza Vaccine Market, By Vaccine Type
6.9.4.2 Spain Seasonal Influenza Vaccine Market, By Valency
6.9.4.3 Spain Seasonal Influenza Vaccine Market, By Age Group
6.9.4.4 Spain Seasonal Influenza Vaccine Market, By Distribution Channel
6.9.5 Rest of Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.9.5.1 Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type
6.9.5.2 Rest of Europe Seasonal Influenza Vaccine Market, By Valency
6.9.5.3 Rest of Europe Seasonal Influenza Vaccine Market, By Age Group
6.9.5.4 Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel
7. Asia Pacific Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Seasonal Influenza Vaccine Market: Snapshot
7.2 Asia Pacific Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.3 Asia Pacific Seasonal Influenza Vaccine Market: Key Factors
7.4 Asia Pacific Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
7.4.1 Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type Overview
7.4.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
7.4.3 Asia Pacific Seasonal Influenza Vaccine Market Size, Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
7.5 Asia Pacific Seasonal Influenza Vaccine Market Segmentation: By Valency
7.5.1 Asia Pacific Seasonal Influenza Vaccine Market, By Valency Overview
7.5.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
7.5.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
7.6 Asia Pacific Seasonal Influenza Vaccine Market Segmentation: By Age Group
7.6.1 Asia Pacific Seasonal Influenza Vaccine Market, By Age Group Overview
7.6.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
7.6.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
7.6.4 Asia Pacific Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
7.7 Asia Pacific Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Seasonal Influenza Vaccine Market, By Distribution Channel Overview
7.7.2 Asia Pacific Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
7.7.3 Asia Pacific Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
7.7.4 Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
7.8 Asia Pacific Seasonal Influenza Vaccine Market Segmentation: By Country
7.8.1 China Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.1.1 China Seasonal Influenza Vaccine Market, By Vaccine Type
7.8.1.2 China Seasonal Influenza Vaccine Market, By Valency
7.8.1.3 China Seasonal Influenza Vaccine Market, By Age Group
7.8.1.4 China Seasonal Influenza Vaccine Market, By Distribution Channel
7.8.2 Japan Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.2.1 Japan Seasonal Influenza Vaccine Market, By Vaccine Type
7.8.2.2 Japan Seasonal Influenza Vaccine Market, By Valency
7.8.2.3 Japan Seasonal Influenza Vaccine Market, By Age Group
7.8.1.4 Japan Seasonal Influenza Vaccine Market, By Distribution Channel
7.8.3 Australia Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.3.1 Australia Seasonal Influenza Vaccine Market, By Vaccine Type
7.8.3.2 Australia Seasonal Influenza Vaccine Market, By Valency
7.8.3.3 Australia Seasonal Influenza Vaccine Market, By Age Group
7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel
7.8.4 South Korea Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.3.1 South Korea Seasonal Influenza Vaccine Market, By Vaccine Type
7.8.3.2 South Korea Seasonal Influenza Vaccine Market, By Valency
7.8.3.3 South Korea Seasonal Influenza Vaccine Market, By Age Group
7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel
7.8.5 Rest of APAC Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.5.1 Rest of APAC Seasonal Influenza Vaccine Market, By Vaccine Type
7.8.5.2 Rest of APAC Seasonal Influenza Vaccine Market, By Valency
7.8.5.3 Rest of APAC Seasonal Influenza Vaccine Market, By Age Group
7.8.5.4 Rest of APAC Seasonal Influenza Vaccine Market, By Distribution Channel
8. Middle East & Africa Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)
8.1 Middle East & Africa Seasonal Influenza Vaccine Market: Snapshot
8.2 Middle East & Africa Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
8.3 Middle East & Africa Seasonal Influenza Vaccine Market: Key Factors
8.4 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation: By Vaccine Type
8.4.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Vaccine Type Overview
8.4.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
8.4.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
8.5 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation: By Valency
8.5.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Valency Overview
8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
8.6 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation: By Age Group
8.6.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Age Group Overview
8.6.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
8.7 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
8.7.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
8.7.4 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Seasonal Influenza Vaccine Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Porter Analysis
11. Competitive Positioning
11.1 Recommended Seasonal Influenza Vaccines for Different Age Groups
11.2 Market Share of Prominent Companies
11.3 Company Profiling
11.3.1 CSL Seqirus
11.3.2 GlaxoSmithKline
11.3.3 Sanofi
11.3.4 AstraZeneca PLC
11.3.5 Abbott Laboratories
11.3.6 Viatris
11.3.7 Sinovac Biotech
11.3.8 Serum Institute of India
11.3.9 Daiichi Sankyo
11.3.10 Dalian Aleph Biomedical
List of Figures
Figure 1: Influenza Vaccination Rates, Total % of population aged 65 and Above
Figure 2: Global Seasonal Influenza Vaccine Market Size, By Value, 2019-2022 (USD Million)
Figure 3: Global Seasonal Influenza Vaccine Market Size, By Value, 2023-2029 (USD Million)
Figure 4: Global Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
Figure 5: Global Seasonal Influenza Vaccine Market Size, By Volume, 2019-2022 (Billion Doses)
Figure 6: Global Seasonal Influenza Vaccine Market Size, By Volume, 2023-2029 (Billion Doses)
Figure 7: Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 8: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Inactivated Influenza Vaccine (IIV), 2019H-2029F (USD Million)
Figure 9: Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 10: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Live Attenuated Influenza Vaccine (LAIV), 2019H-2029F (USD Million)
Figure 11: Global Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 12: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Quadrivalent, 2019H-2029F (USD Million)
Figure 13: Global Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 14: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Trivalent, 2019H-2029F (USD Million)
Figure 15: Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 16: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Pediatrics, 2019H-2029F (USD Million)
Figure 17: Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
Figure 18: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Adults, 2019H-2029F (USD Million)
Figure 19: Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
Figure 20: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Elderly, 2019H-2029F (USD Million)
Figure 21: Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
Figure 22: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Hospitals, 2019H-2029F (USD Million)
Figure 23: Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 24: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Pharmacies, 2019H-2029F (USD Million)
Figure 25: Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
Figure 26: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Government Supply, 2019H-2029F (USD Million)
Figure 27: Americas Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
Figure 28: Americas Seasonal Influenza Vaccine Market Share, By Vaccine Type, 2022 (%)
Figure 29: Americas Seasonal Influenza Vaccine Market , By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 30: Americas Seasonal Influenza Vaccine Market , By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Americas Seasonal Influenza Vaccine Market , By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 32: Americas Seasonal Influenza Vaccine Market , By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 33: Americas Seasonal Influenza Vaccine Market , By Pediatrics Age Group, By Value, 2019H-2029F (USD Million & CAGR)
Figure 34: Americas Seasonal Influenza Vaccine Market , By Adults Age Group, By Value, 2019H-2029F (USD Million & CAGR)
Figure 35: Americas Seasonal Influenza Vaccine Market , By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
Figure 36: Americas Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
Figure 37: Americas Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 38: Americas Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
Figure 39: United States Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 40: United States Seasonal Influenza Vaccine Market Value, By Valency, 2022 (USD Million)
Figure 41: United States Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 42: United States Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 43: United States Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 44: United States Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 45: Canada Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 46: Canada Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 47: Canada Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 48: Canada Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 49: Canada Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 50: Canada Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 51: Rest of Americas Seasonal Influenza Vaccine Market , By Value, 2019H-2029F (USD Million & CAGR)
Figure 52: Rest of Americas Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 53: Rest of Americas Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 54: Rest of Americas Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 55: Rest of Americas Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 56: Rest of Americas Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 57: Europe Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
Figure 58: Europe Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
Figure 59: Europe Seasonal Influenza Vaccine Market, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Europe Seasonal Influenza Vaccine Market, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: Europe Seasonal Influenza Vaccine Market, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 62: Europe Seasonal Influenza Vaccine Market, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 63: Europe Seasonal Influenza Vaccine Market, By Pediatrics Age Group, By Value, 2019H-2029F (USD Million & CAGR)
Figure 64: Europe Seasonal Influenza Vaccine Market, By Adults Age Group, By Value, 2019H-2029F (USD Million & CAGR)
Figure 65: Europe Seasonal Influenza Vaccine Market, By Elderly Age Group, By Value, 2019H-2029F (USD Million & CAGR)
Figure 66: Europe Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
Figure 67: Europe Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 68: Europe Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
Figure 69: Germany Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 70: Germany Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 71: Germany Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 72: Germany Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 73: Germany Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 74: Germany Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 75: United Kingdom Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 76: United Kingdom Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 77: United Kingdom Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 78: United Kingdom Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 79: United Kingdom Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 80: United Kingdom Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 81: France Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 82: France Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 83: France Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 84: France Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 85: France Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 86: France Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 87: Spain Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 88: Spain Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 89: Spain Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 90: Spain Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 91: Spain Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 92: Spain Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 93: Rest of Europe Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 94: Rest of Europe Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 95: Rest of Europe Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 96: Rest of Europe Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 97: Rest of Europe Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 98: Rest of Europe Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 99: Asia Pacific Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
Figure 100: Asia Pacific Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
Figure 101: Asia Pacific Seasonal Influenza Vaccine Market, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 102: Asia Pacific Seasonal Influenza Vaccine Market, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
Figure 103: Asia Pacific Seasonal Influenza Vaccine Market, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 104: Asia Pacific Seasonal Influenza Vaccine Market, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
Figure 105: Asia Pacific Seasonal Influenza Vaccine Market, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
Figure 106: Asia Pacific Seasonal Influenza Vaccine Market, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
Figure 107: Asia Pacific Seasonal Influenza Vaccine Market, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
Figure 108: Americas Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
Figure 109: Americas Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 110: Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
Figure 111: China Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 112: China Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 113: China Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 114: China Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 115: China Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 116: China Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 117: Japan Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 118: Japan Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 119: Japan Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 120: Japan Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 121: Japan Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 122: Japan Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 123: Australia Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
Figure 124: Australia Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
Figure 125: Australia Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
Figure 126: Australia Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
Figure 127: Australia Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
Figure 128: Australia Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
Figure 129: South Korea Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD

Table Information

Report AttributeDetails
No. of Pages280
PublishedJuly 2023
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 6.5 Billion
Forecasted Market Value ( USD ) by 2029 $ 9.3 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal

Related Topics

Related Reports

Influenza Vaccines Global Market Report 2024 - Product Image

Influenza Vaccines Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Influenza Vaccine Market: Analysis by Valency, By Vaccine Type, By Technology, By Age Group, By Route Of Administration, By Distribution Channel, By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 - Product Image

Global Influenza Vaccine Market: Analysis by Valency, By Vaccine Type, By Technology, By Age Group, By Route Of Administration, By Distribution Channel, By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028

  • Report
  • 165 Pages
  • Global
From
Seasonal Influenza Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Seasonal Influenza Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From
Global Influenza Vaccine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Global Influenza Vaccine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 139 Pages
  • Global
From
Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By Distribution Channel; and By Region - Product Image

Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From

About the Flu Vaccine Market

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions. Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques. Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.